Professor Eli Gabbay

Dr Gabbay graduated from University of Western Australia Medical School in 1987 and undertook specialist training in Respiratory Medicine at Royal Perth Hospital. He undertook subspecialty training at the Freeman Hospital in Newcastle upon Tyne, Stanford University Palo Alto and the Alfred Hospital, Melbourne before returning to Perth to set up WA’s first advanced lung and pulmonary vascular disease program. In 2004, he became the inaugural medical director of the WA Lung Transplant Program. Dr Gabbay has over 20 years experience in the assessment and management of pulmonary hypertension and currently heads the largest private practice based clinic in Pulmonary Hypertension in Australia.

He is Professor of Respiratory Medicine at The University of Notre Dame (Australia) and Chair of Research at Notre Dame Medical School. Dr Gabbay is a Clinical Professor at The University of Western Australia Medical School and Associate Professor at Curtin University School of Physiotherapy. He is Head of the Advanced Lung Disease and Pulmonary Vascular Unit at the Lung Institute of Western Australia. His group has received over 2,000,000 dollars in competitive grants (including NH and MRC grants) and Professor Gabbay has co-authored over 160 peer reviewed publications including book chapters and invited reviews.

Dr Gabbay is the immediate past editor of Advances in Pulmonary Hypertension and has peer reviewed several hundred research papers in Pulmonary Vascular Disease and Pulmonary Hypertension and advises the NH and MRC, Wellcome Trust UK, Heart Foundation and Numerous Hospital and Universities on Grant applications in pulmonary vascular disease.

Professor Gabbay was an inaugural board member of the PHSANZ, (Pulmonary Hypertension Society of Australia and New Zealand) and has been chair of the Australian Lung Foundation Expert Committee on management of Pulmonary Hypertension. Professor Gabbay is a Judge for The Premier of Western Australia Science Awards.